• Home>
  • Stocks>
  • Caplin Point Laboratories Ltd Share Price
bell
The current prices are delayed by 15 mins, login to check live prices.
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd Share Price

(CAPLIPOINT)

₹2001.75▲5.41%

as on 04:01PM, 29 Jan 2025

Overview
News
Financials
Q3 FY24-25 Results
Technicals

Caplin Point Laboratories Ltd Analyst Rating

based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts offering long term price targets for Caplin Point Laboratories Ltd. An average target of ₹2396.67

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Share analysis

Caplin Point Laboratories Ltd price forecast by 3 analysts

Upside of26.21%

High

₹2510

Target

₹2396.67

Low

₹2280

Caplin Point Laboratories Ltd target price ₹2396.67, a slight upside of 26.21% compared to current price of ₹2001.75. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹1,876.85
    Day's Price Range
    ₹2,020

  • 52 Week's Low

    52 Week's High

    ₹1,225
    52-Week Price Range
    ₹2,641
1 Month Return-25.18 %
3 Month Return+ 1.6 %
1 Year Return+ 33.7 %
Previous Close₹1,898.95
Open₹1,876.85
Volume1.71L
Upper Circuit-
Lower Circuit-
Market Cap₹14,434.24Cr

Caplin Point Laboratories Ltd Key Statistics

P/E Ratio29.22
PEG Ratio2.94
Market Cap₹14,434.24 Cr
P/B Ratio7.2
EPS60.75
Dividend Yield0.38
SectorPharmaceuticals
ROE22.43

Caplin Point Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd
BUY₹14,434.24 Cr112.22%0.50₹461 Cr₹1,694 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹24,827.72 Cr95.74%0.52₹300 Cr₹1,051 Cr
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹14,049.46 Cr13.69%0.57₹72 Cr₹6,702 Cr
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹5,258.87 Cr-3.9%0.79-₹388 Cr₹75 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹13,961.83 Cr41.08%0.68₹218 Cr₹1,296 Cr
See all

Caplin Point Laboratories Ltd Mutual Fund Holdings

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Share Price: ₹2001.75 per share as on 29 Jan, 2025 04:01 PM
Market Capitalisation: ₹14,434.24Cr as of today
Revenue: ₹483.10Cr as on September 2024 (Q3 24)
Net Profit: ₹130.81Cr as on September 2024 (Q3 24)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Caplin Point Laboratories Ltd

  • FIIs Increase Stake in Caplin Point Laboratories - 25 Jan, 2025

    Foreign Institutional Investors have raised their stake in Caplin Point Laboratories from 3.71% in Q2FY25 to 4.86% in Q3FY25, reflecting growing confidence in the company.

  • Caplin Point Secures USFDA Approval for Injection - 17 Jan, 2025

    Caplin Point Laboratories' subsidiary, Caplin Steriles, has received USFDA approval for Levetiracetam in Sodium Chloride Injection, a significant milestone with potential US sales of $19 million.

  • Caplin Point Passes FDA Inspection with Zero Observations - 06 Jan, 2025

    Caplin Point Laboratories announced that its Gummidipoondi facility received an Establishment Inspection Report from the FDA, concluding an unannounced inspection with zero 483 observations, highlighting compliance with regulatory standards.

  • Caplin Point's Growth and Valuation Insights - 04 Jan, 2025

    Caplin Point has achieved 260% returns since July 2022, with strong revenue growth. However, rising valuations and global trade volatility pose risks. Investors are advised to hold.

  • Caplin Point's Strong Market Position Highlighted - 02 Jan, 2025

    Caplin Point Laboratories is recognized for its strong position in the Latin American market and is making significant progress in US sales, indicating positive growth potential.

  • Caplin Point Laboratories Shows Strong Bullish Momentum - 31 Dec, 2024

    Caplin Point Laboratories experienced a bullish breakout, rising nearly 9% with significant volumes. The stock breached resistance levels, forming a new high at ₹2,641, supported by strong technical indicators.

  • Caplin Point Laboratories Faces Short-Term Decline - 30 Dec, 2024

    On December 30, 2024, Caplin Point Laboratories' stock declined by 5.4%, reaching an intraday low of Rs 2476.8. Despite this, the stock has gained 13.73% over the past month, outperforming the Sensex, which fell by 1.57%. The stock remains above all key moving averages, indicating a generally positive trend.

  • Caplin Point Laboratories Hits New 52-Week High - 27 Dec, 2024

    On December 27, 2024, Caplin Point Laboratories reached a new 52-week high of Rs. 2576.95, gaining 7.61% and significantly outperforming the Sensex and its sector.

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 17 quarters, 269.88 Cr → 503.87 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.62% to 1.86% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 12 quarters, 74.95 Cr → 130.8 Cr (in ₹), with an average increase of 4.9% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.70% to 4.86% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.5% return, outperforming this stock by 17.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.2% return, outperforming this stock by 9.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 23.90% to 22.47% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CAPLIPOINT stock has moved down by -12.8%

Caplin Point Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹410.06Cr (-)₹435.50Cr (↑6.20%)₹453.22Cr (↑4.07%)₹458.96Cr (↑1.27%)₹483.10Cr (↑5.26%)
Net Income₹116.14Cr (-)₹119.82Cr (↑3.17%)₹121.23Cr (↑1.18%)₹124.92Cr (↑3.04%)₹130.81Cr (↑4.72%)
Net Profit Margin28.32% (-)27.51% (↓2.86%)26.75% (↓2.76%)27.22% (↑1.76%)27.08% (↓0.51%)
Value in ₹ crore
Details2021202220232024
Total Assets₹860.99Cr (-)₹1,054.16Cr (↑22.44%)₹1,303.18Cr (↑23.62%)₹1,522.31Cr (↑16.82%)
Total Liabilities₹102.32Cr (-)₹123.51Cr (↑20.71%)₹163.27Cr (↑32.19%)₹132.16Cr (↓19.05%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹87.01Cr (-)₹294.64Cr (↑238.63%)₹230.97Cr (↓21.61%)₹157.10Cr (↓31.98%)₹111.01Cr (↓29.34%)

Index Inclusions

S&P BSE 250 SmallCap

₹6,272.69

3.1 (▲188.58%)

BSE Healthcare

₹41,149.54

2.2 (▲885.32%)

Nifty Smallcap 250

₹15,613.35

3.16 (▲478.25%)

Nifty 500

₹21,245.50

1.53 (▲320.75%)

S&P BSE 400 MidSmallCap

₹11,022.16

2.72 (▲292.17%)

BSE 500

₹33,434.59

1.53 (▲503.74%)

Nifty MidSmallcap 400

₹18,103.90

2.69 (▲474%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

BSE Small-Cap

₹49,050.57

3.28 (▲1558.09%)

Caplin Point Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.56%
0.00
Foreign Institutions
4.86%
31.42
Mutual Funds
1.86%
14.58
Retail Investors
22.47%
-5.99
Others
0.25%
15.46

Caplin Point Laboratories Ltd Key Indicators

Details20202021202220232024
Return On Equity %38.32322.2422.6322.43
Details20202021202220232024
Return On Assets %31.128.1428.4428.8730.03
Details20202021202220232024
Book Value Per Share (₹)96.68128.12167.2219.22276.38
Details20202021202220232024
Earning Per Share (₹)28.4333.2440.6949.6760.75

Caplin Point Laboratories Ltd Valuation

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (29.22x)

January 28, 2025

Industry (53.05x)

January 28, 2025

Highest (40.01x)

December 27, 2024

LowHigh

Caplin Point Laboratories Ltd Earnings and Dividends

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 13.87% since last year same period to ₹130.80Cr in the Q2 2024-2025. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 5.51% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2024

    In the quarter ending June 2024, Caplin Point Laboratories Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.40%.

    Read More about Dividends

Caplin Point Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Caplin Point Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Caplin Point Laboratories Ltd

What is Caplin Point Laboratories Ltd price today?

Caplin Point Laboratories Ltd share price today stands at ₹2001.75, Open: ₹1876.85, Previous Close: ₹1898.95, High: ₹2020, Low: ₹1876.85, 52 Week High: ₹2641, 52 Week Low: ₹1225.

How to Buy Caplin Point Laboratories Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Caplin Point Laboratories Ltd shares

Is Caplin Point Laboratories Ltd listed on NSE?

Caplin Point Laboratories Ltd is listed on NSE

Is Caplin Point Laboratories Ltd listed on BSE?

Caplin Point Laboratories Ltd is listed on BSE

What are today's High and Low prices of Caplin Point Laboratories Ltd?

  • Today's highest price of Caplin Point Laboratories Ltd is ₹2020.
  • Today's lowest price of Caplin Point Laboratories Ltd is ₹1876.85.

What are today's traded volumes of Caplin Point Laboratories Ltd?

Today's traded volume of Caplin Point Laboratories Ltd(CAPLIPOINT) is 1.71L.

What is today's market capitalisation of Caplin Point Laboratories Ltd?

Today's market capitalisation of Caplin Point Laboratories Ltd(CAPLIPOINT) is ₹14434.24Cr.

What is the 52 Week High and Low Range of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd (CAPLIPOINT)
Price
52 Week High
₹2641
52 Week Low
₹1225

How much percentage Caplin Point Laboratories Ltd is down from its 52 Week High?

Caplin Point Laboratories Ltd (CAPLIPOINT) share price is ₹2001.75. It is down -24.20% from its 52 Week High price of ₹2641

How much percentage Caplin Point Laboratories Ltd is up from its 52 Week low?

Caplin Point Laboratories Ltd (CAPLIPOINT) share price is ₹2001.75. It is up 63.41% from its 52 Week Low price of ₹1225

What are the historical returns of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd (CAPLIPOINT)
Returns
1 Day Returns
102.8%
1 Month Returns
-25.18%
3 Month Returns
1.6%
1 Year Returns
33.7%

What is the PE ratio of Caplin Point Laboratories Ltd today?

PE Ratio of Caplin Point Laboratories Ltd is 29.22

PE ratio = Caplin Point Laboratories Ltd Market price per share / Caplin Point Laboratories Ltd Earnings per share